Delivery Order SPE2DR25D3301-SPE2DR26F23LC
Award Date 3/3/26
Potential Completion Date 3/4/26
Potential Value $6.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $1,213.38 delivery order to AmerisourceBergen Drug Corp on February 27, 2026, for supply of Qnasal 80 MCG nasal spray (10.6 GM). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 and running through December 2026. This prime vendor contract supplies pharmaceutical products and medical commodities globally to support military healthcare programs. Place of performance is Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,542.48 to AmerisourceBergen Drug Corp for QNASL 80 MCG Nasal Spray (10.6 GM) with a completion deadline of September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the agency's medical supply chain operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Qnasl 80 mcg nasal spray (10.6 grams) with a contract ceiling value of $2,486.72 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of June 2, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Qnasl 80 micrograms nasal spray (10.6 grams) with a ceiling value of $1,487.76. This competitively awarded, firm fixed-price contract is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 6, 2026. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Qnasl 80 mcg nasal spray (10.6 grams) with a ceiling value of $4,980.26. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $359,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561880875 nasal spray. The prime contractor will provide 10.6 grams of QNASL 80 microgram nasal spray to fulfill requirements under the contract. Performance will take place in Conshohocken, Pennsylvania from August 21-22, 2023. The Defense Logistics Agency facilitates worldwide logistics support for the United States Department of Defense and partners, and this delivery...
- This delivery order, awarded September 5, 2025, provides QNASL 80 MCG nasal spray (10.6 GM) to the Defense Logistics Agency (DLA) through AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract represents a firm fixed-price delivery order with a ceiling value of $4,189.84 and an ultimate completion date of September 8, 2025. The award was competitively awarded with no set-aside designation,...
- This is a $1,899.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a pharmaceutical product, with a performance period through April 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support...
- The Defense Logistics Agency awarded a $723.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562054918 QNASL 80 MCG NASAL SPRAY 10.6GM. The single day contract running from September 5-6, 2023 calls for Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, to provide nasal spray products to the DLA in support of the agency's medical supply procurement programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No...
- This is a $1,322.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QNASL 80 MCG nasal spray. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F23LCDelivery Order
The Defense Logistics Agency issued a $6,637.05 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for QNASL 80 MCG nasal spray (10.6 GM) with an ultimate completion date of March 4, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. The parent vehicle is an Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, supporting global pharmaceutical supply to military healthcare programs.
Generated 6/1/26, 10:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 3/2/26 |